S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › 0RPY › Research report
← 0RPY page
XStocksXray
Market X-Ray report · 19 October 2026

Boozt AB (0RPY)

London Exchange · UK · prices in SEK · close of 19 Oct 2026

Key indicators

Last closeSEK 155.65
52-week range85.15 – 168.20
Return, 1 month / 3 months+10.5% / −2.8%
Return, 1 year / 3 years+48.8% / +81.9%
TrendUptrend
RSI (14)57
Volatility (1 year)35.7%
Worst drawdown (1 year)-25.4%
Average daily value traded1.39M SEK
Dividend yield–

Market X-Ray price-based

68/ 100 · High confidence · ahead of 83% of stocks on this exchange
Trend86
Momentum71
Stability (higher is calmer)54
Liquidity56
Income–

Five-year price chart navy: price · brown: 200-day average

48.2283.521191541892021-102023-012024-042025-072026-10

About the company

Boozt AB is a Nordic online retailer of fashion and lifestyle products, based in Malmö, Sweden. Through its web stores it offers clothing, shoes and accessories for women, men and children, bringing together many external brands alongside its own labels. Its customers are shoppers across the Nordic countries and beyond who buy apparel and related goods online, and the company handles the logistics and delivery of those orders itself.

On this site Boozt AB appears as a stock on the London Exchange (UK), code 0RPY, with prices in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Boozt AB (0RPY) trades on the London Exchange in UK. It last closed at SEK 155.65 on 19 October 2026.

Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 663 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 48.8% and over the last three months it fell 2.8%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Boozt AB (0RPY)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend86 · StrongTrading above its long-term averages and near its highs.
Above 200-day average24.3%
From 52-week high-6.9%
Momentum71 · StrongRising faster than most stocks on this exchange.
3-month return-2.8%
6-month return38.3%
12-month return, skipping the last month34.6%
Stability (higher is calmer)54 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)35.7%
Worst drawdown, 1 year (smaller is calmer)-25.4%
Liquidity56 · FairModerate trading activity.
Average daily value traded1.39M SEK
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.

Weak spots

No lens is weak against its exchange.

Returns

1 week+2.1%
1 month+10.5%
3 months−2.8%
6 months+38.3%
1 year+48.8%
3 years+81.9%
5 years–

Signals

50-day / 200-day average149.93 / 125.23
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)3.64

Technical summary

DailyStrongly bullish12 bullish · 3 neutral · 1 bearish
WeeklyStrongly bullish10 bullish · 1 neutral · 1 bearish
MonthlyStrongly bullish7 bullish · 1 neutral · 0 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026